From: The prevalence of thyroid dysfunction in Jordan: a national population-based survey
Variables | aTotal hypothyroidism | bTotal hyperthyroidism | ||
---|---|---|---|---|
OR (CI) | P-value | OR (CI) | P-value | |
Sex | ||||
Male | 1 | 0.000 | 1 | 0.757 |
Female | 1.86 (1.32–2.60) | 1.06 (0.72–1.58) | ||
Age (years) | ||||
18–29 | 1 | 1 | ||
30–39 | 1.13 (0.72–1.77) | 0.597 | 1.29 (0.68–2.48) | 0.430 |
40–49 | 1.34 (0.88–2.02) | 0.164 | 1.38 (0.75–2.54) | 0.293 |
50–59 | 1.65 (1.08–2.51) | 0.018 | 1.85 (1.01–3.40) | 0.047 |
≥ 60 | 1.64 (1.03–2.62) | 0.039 | 2.12 (1.12–4.01) | 0.020 |
Thyroid peroxidase antibody (TPOAb) | ||||
Negative | 1 | 0.000 | 1 | 0.014 |
positive | 7.42 (5.40–10.20) | 1.93 (1.14–3.27) | ||
Thyroglobulin antibody (TgAb) | ||||
Negative | 1 | 0.000 | 1 | 0.327 |
positive | 1.98 (1.44–2.74) | 0.75 (0.42–1.33) |